Reportlinker Adds Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
NEW YORK, Dec. 8, 2010 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Summary
GlobalData's new report, "Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" provides key data, information and analysis on the global orthobiologics market. The report provides market landscape, competitive landscape and market trends information the orthobiologics market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, France, Italy, Spain, Japan, China, India, Australia, and Brazil.
- Key segments covered include Bone Allografts, Bone Graft Substitutes (Synthetic Bone Graft Substitutes, and bone morphogenic proteins), Bone Growth Stimulators, Demineralized Bone Matrix (DBM), and Viscosupplementation.
- Annualized market revenues data from 2002 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within orthobiologics market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, Genzyme Corporation, DePuy, Synthes, Smith & Nephew, and Stryker Corporation.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the orthobiologics market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next being thing in the orthobiologics market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global orthobiologics market and the factors shaping it.
1 Table of contents 3
1.1 List of Tables 6
1.2 List of Figures 8
2 Introduction: Orthobiologics 9
2.1 GlobalData Report Guidance 9
3 Overview: Orthobiologics 10
3.1 Applications of Orthobiologics 11
4 Global Orthobiologics Market Characterization 12
4.1 Global Orthobiologics Market, Revenue ($m), Historic, 2002 – 2009 12
4.2 Global Orthobiologics Market, Revenue ($m), Forecast, 2009 – 2016 13
4.3 Global Orthobiologics, Market Dynamics 14
4.3.1 Orthobiologics, Market Drivers 15
4.3.2 Orthobiologics, Market Restraints 17
5 Global Orthobiologics Market: Segment Analysis 18
5.1 Global Bone Graft Substitutes Market, Revenue ($m), Historic, 2002 – 2009 18
5.2 Global Bone Graft Substitutes Market, Revenue ($m), Forecast, 2009 – 2016 19
5.2.1 Bone Graft Substitutes, Market Drivers 20
5.2.2 Bone Graft Substitutes, Market Restraint: Safety Concerns over Bone Morphogenetic Protein (BMP) in Spinal Fusion Surgeries and High Cost is Slowing the Adoption 20
5.3 Global Viscosupplementation Market, Revenue ($m), Historic, 2002 – 2009 21
5.4 Global Viscosupplementation Market, Revenue ($m), Forecast, 2009 – 2016 22
5.4.1 Viscosupplementation, Market Drivers 23
5.4.2 Viscosupplementation, Market Restraint: Pricing Challenges to Continue to Plague the Viscosupplementation Market 23
5.5 Global DBM Market, Revenue ($m), Historic, 2002 – 2009 24
5.6 Global DBM Market, Revenue ($m), Forecast, 2009 – 2016 25
5.6.1 DBM, Market Drivers 26
5.6.2 DBM, Market Restraint: Several Potential Disadvantages such as potential to transmit human immunodeficiency virus may Act as Restraint for Market Growth 26
5.7 Global Bone Growth Stimulators Market, Revenues ($m), Historic, 2002 – 2009 27
5.8 Global Bone Growth Stimulators Market, Revenues ($m), Forecast, 2009 – 2016 28
5.8.1 Bone Growth Stimulators, Market Driver: Increasing Number of Fractures due to Ageing is Expected to Drive the Market Growth for Bone Growth Stimulators 28
5.8.2 Bone Growth Stimulators, Market Restraint: Lack of Exact Knowledge about the Mechanism of Action for These Devices and Lack of Studies in Specific Patient Groups will Restrict their Adoption 29
5.9 Global Bone Allografts Market, Revenue ($m), Historic, 2002-2009 29
5.10 Global Bone Allografts Market, Revenue ($m), Forecast, 2009-2016 30
5.10.1 Bone Allografts, Market Drivers: The advantages offered by allografts over autografts - the elimination of second surgery to drive the market 31
5.10.2 Bone Allografts, Market Restraints: Various Complications Associated with Bone Allografts is Restraining their Adoption 31
6 Global Orthobiologics Market, Segment Analysis, 2002-2016 32
6.1 Global Orthobiologics Market, Revenue ($m), By Country, 2002-2016 33
6.1.1 US Orthobiologics Market, Revenue ($m), Historic, 2002-2009 33
6.1.2 US Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 34
6.1.3 Canada Orthobiologics Market, Revenue ($m), Historic, 2002-2009 35
6.1.4 Canada Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 36
6.1.5 Germany Orthobiologics Market, Revenue ($m), Historic, 2002-2009 37
6.1.6 Germany Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 38
6.1.7 UK Orthobiologics Market, Revenue ($m), Historic, 2002-2009 39
6.1.8 UK Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 40
6.1.9 France Orthobiologics Market, Revenue ($m), Historic, 2002-2009 41
6.1.10 France Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 42
6.1.11 Spain Orthobiologics Market, Revenue ($m), Historic, 2002-2009 43
6.1.12 Spain Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 44
6.1.13 Italy Orthobiologics Market, Revenue ($m), Historic, 2002-2009 45
6.1.14 Italy Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 46
6.1.15 Japan Orthobiologics Market, Revenue ($m), Historic, 2002-2009 47
6.1.16 Japan Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 48
6.1.17 China Orthobiologics Market, Revenue ($m), Historic, 2002-2009 49
6.1.18 China Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 50
6.1.19 India Orthobiologics Market, Revenue ($m), Historic, 2002-2009 51
6.1.20 India Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 52
6.1.21 Australia Orthobiologics Market, Revenue ($m), Historic, 2002-2009 53
6.1.22 Australia Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 54
6.1.23 Brazil Orthobiologics Market, Revenue ($m), Historic, 2002-2009 55
6.1.24 Brazil Orthobiologics Market, Revenue ($m), Forecast, 2009-2016 56
7 Global Orthobiologics Market: Strategic Competitive Assessment 57
7.1 Medtronic Inc. 58
7.1.1 Overview: 58
7.2 Genzyme Corporation 59
7.2.1 Overview 59
7.3 Depuy, Inc.(Johnson & Johnson) 60
7.3.1 Overview 60
7.4 Synthes, Inc. 61
7.4.1 Overview 61
7.5 Smith & Nephew Plc 62
7.5.1 Overview 62
7.6 Stryker 63
7.6.1 Overview 63
7.7 Orthofix International N.V 64
7.7.1 Overview 64
8 Key Orthobiologics in the Market 65
8.1 Bone Graft Substitutes 65
8.1.1 InFUSE (Medtronic, Inc.) 65
8.1.2 OP 1 Putty (Stryker) 65
8.1.3 chronOS (Synthes) 65
8.1.4 Healos Bone Graft Replacement 66
8.2 Viscosupplementation 66
8.2.1 Synvisc-one 66
8.2.2 SUPARTZ 67
8.3 DBM 67
8.3.1 Optium DBM 67
8.3.2 DBX 67
8.3.3 VIAGRAF 68
8.4 Bone Growth Stimulators 68
8.4.1 Exogen 68
8.4.2 Physio-Stim 68
8.5 Bone Allograft 69
8.5.1 Allograft TLIF 69
8.5.2 Allograft PL 69
8.5.3 Trinity Evolution 69
9 Global Orthobiologics Market: Strategic Pipeline Assessment 70
9.1 Orthobiologics Market: Pipeline Products Summary 70
9.2 Profiles of Promising Products Under Clinical Development: 72
9.2.1 Synthetic Bone Graft Substitutes 72
9.2.2 BMP 74
9.2.3 Bone Growth Stimulators 75
9.2.4 Bone Allograft 76
9.2.5 Viscosupplementation 77
9.2.6 DBM 78
9.3 List of Pipeline Products 78
9.3.1 Pipeline Product Summary 78
10 Global Orthobiologics Market: Strategic Deals Analysis 85
10.1 Key Deals 87
10.1.1 Medtronic to Acquire Osteotech 87
10.1.2 Landec Acquires Lifecore Biomedical 87
10.1.3 Baxter International Completes Acquisition Of ApaTech 87
10.1.4 TiGenix Completes Acquisition Of OrthoMimetics 88
10.1.5 NuVasive Invests In Progentix Orthobiology 88
10.1.6 Kinetic Concepts Acquires LifeCell 88
10.1.7 Pioneer Surgical Acquires Angstrom Medica 89
10.1.8 Pioneer Surgical Technology Acquires Encelle 89
10.1.9 Orthofix Acquires Blackstone Medical 89
11 Appendix 90
11.1 Definitions 91
11.1.1 Orthobiologics 91
11.2 Acronyms 91
11.3 References 92
11.4 Research Methodology 92
11.5 Secondary Research 92
11.6 Primary Research 92
11.7 Models 93
11.8 Forecasts 93
11.9 Expert Panels 93
11.10 GlobalData Consulting 94
11.11 Contact Us 94
11.12 Disclaimer 941.1 List of Tables
Table 1: Orthobiologics Market, Global, Revenue ($m), 2002–2009 12
Table 2: Orthobiologics Market, Global, Revenue ($m), 2009–2016 14
Table 3: Bone Graft Substitutes Market, Global, Revenue ($m), 2002–2009 18
Table 4: Bone Graft Substitutes Market, Global, Revenue ($m), 2009–2016 19
Table 5: Viscosupplementation Market, Global, Revenue ($m), 2002–2009 21
Table 6: Viscosupplementation Market, Global, Revenue ($m), 2009–2016 22
Table 7: DBM Market, Global, Revenue ($m), 2002–2009 24
Table 8: DBM Market, Global, Revenue ($m), 2009–2016 25
Table 9: Bone Growth Stimulators Market, Global, Revenue ($m), 2002–2009 27
Table 10: Bone Growth Stimulators Market, Global, Revenue ($m), 2009–2016 28
Table 11: Bone Allografts Market, Global, Revenue ($m), 2002–2009 29
Table 12: Bone Allografts Market, Global, Revenue ($m), 2009–2016 30
Table 13: Orthobiologics Market, Global, Segment Analysis, 2002 – 2016 32
Table 14: Orthobiologics Market, US, Revenue ($m), 2002-2009 33
Table 15: Orthobiologics Market, US, Revenue ($m), 2009-2016 34
Table 16: Orthobiologics Market, Canada, Revenue ($m), 2002-2009 35
Table 17: Orthobiologics Market, Canada, Revenue ($m), 2009-2016 36
Table 18: Orthobiologics Market, Germany, Revenue ($m), 2002-2009 37
Table 19: Orthobiologics Market, Germany, Revenue ($m), 2009-2016 38
Table 20: Orthobiologics Market, UK, Revenue ($m), 2002-2009 39
Table 21: Orthobiologics Market, UK, Revenue ($m), 2009-2016 40
Table 22: Orthobiologics Market, France, Revenue ($m), 2002-2009 41
Table 23: Orthobiologics Market, France, Revenue ($m), 2009-2016 42
Table 24: Orthobiologics Market, Spain, Revenue ($m), 2002-2009 43
Table 25: Orthobiologics Market, Spain, Revenue ($m), 2009-2016 44
Table 26: Orthobiologics Market, Italy, Revenue ($m), 2002-2009 45
Table 27: Orthobiologics Market, Italy, Revenue ($m), 2009-2016 46
Table 28: Orthobiologics Market, Japan, Revenue ($m), 2002-2009 47
Table 29: Orthobiologics Market, Japan, Revenue ($m), 2009-2016 48
Table 30: Orthobiologics Market, China, Revenue ($m), 2002-2009 49
Table 31: Orthobiologics Market, China, Revenue ($m), 2009-2016 50
Table 32: Orthobiologics Market, India, Revenue ($m), 2002-2009 51
Table 33: Orthobiologics Market, India, Revenue ($m), 2009-2016 52
Table 34: Orthobiologics Market, Australia, Revenue ($m), 2002-2009 53
Table 35: Orthobiologics Market, Australia, Revenue ($m), 2009-2016 54
Table 36: Orthobiologics Market, Brazil, Revenue ($m), 2002-2009 55
Table 37: Orthobiologics Market, Brazil, Revenue ($m), 2009-2016 56
Table 38: Orthobiologics, Key Company Revenues ($m), Global 57
Table 39: Medtronic, Inc. , Marketed Products, 2010 58
Table 40: Medtronic, Pipeline Products, 2010 59
Table 41: Genzyme Corporation, Marketed Products, 2010 59
Table 42: Depuy, Marketed Products, 2010 60
Table 43: Depuy, Pipeline Products, 2010 60
Table 44: Synthes, Inc, Marketed Products, 2010 61
Table 45: Smith & Nephew, Marketed Products, 2010 62
Table 46: Smith & Nephew , Pipeline Products, 2010 62
Table 47: Stryker, Marketed Products, 2010 63
Table 48: Stryker , Pipeline Products, 2010 63
Table 49: Orthofix International, Marketed Products, 2010 64
Table 50: Orthofix International , Pipeline Products, 2010 64
Table 51: Infuse Bone Graft and the LT-Cage Device, Features and Benefits 65
Table 52: OP 1 Putty, Features and Benefits 65
Table 53: chronOS, Features and Benefits 66
Table 54: Healos Bone Graft Replacement, Features and Benefits 66
Table 55: Synvisc-one, Features and Benefits 66
Table 56: SUPARTZ, Features and Benefits 67
Table 57: Optium DBM, Features and Benefits 67
Table 58: DBX; Features and Benefits 67
Table 59: VIAGRAF, Features and Benefits 68
Table 60: Exogen, Features and Benefits 68
Table 61: Physio-Stim, Features and Benefits 68
Table 62: Allograft TLIF, Features and Benefits 69
Table 63: Allograft PL, Features and Benefits 69
Table 64: Trinity Evolution, Features and Benefits 69
Table 65: Pipeline Products, Orthobiologics, by Development Stage, Global, 2010 70
Table 66: Pipeline Products, Orthobiologics, by Segment, Global, 2010 71
Table 67: To Evaluate The Safety And Effectiveness Of GEM OS1 Compared To Autologous Bone Graft As A Bone Regeneration Device In Foot And Ankle Fusions 72
Table 68: The Efficacy Of rhBMP-2 For Posterolateral Lumbar Fusion In Smokers. 74
Table 69: Orthobiologics, Pipeline Products, BMP, 2010 78
Table 70: Orthobiologics, Pipeline Products, Bone Allografts, 2010 79
Table 71: Orthobiologics, Pipeline Products, Bone Graft Substitutes, 2010 79
Table 72: Orthobiologics, Pipeline Products, Bone Growth Stimulators, 2010 80
Table 73: Orthobiologics, Pipeline Products, DBM, 2010 80
Table 74: Orthobiologics, Pipeline Products, Synthetic Bone Graft Substitutes, 2010 81
Table 75: Orthobiologics, Pipeline Products, Viscosupplementation, 2010 82
Table 76: Orthobiologics, Pipeline Products, Others, 2010 82
Table 77: Orthobiologics, Pipeline Products, Others, 2010 83
Table 78: Orthobiologics, Pipeline Products, Others, 2010 84
Table 79: Orthobiologics Market, Key Deals, 2006–2010* 851.2
List of Figures
Figure 1: Orthobiologics, Market Segments, 2010 10
Figure 2: Orthobiologics Market, Global, Revenue ($m), 2002–2009 12
Figure 3: Orthobiologics Market, Global, Revenue ($m), 2009–2016 13
Figure 4: Orthobiologics Market, Drivers and Restraints 14
Figure 5: Bone Graft Substitutes Market, Global, Revenue ($m), 2002–2009 18
Figure 6: Bone Graft Substitutes Market, Global, Revenue ($m), 2009–2016 19
Figure 7: Viscosupplementation Market, Global, Revenue ($m), 2002–2009 21
Figure 8: Viscosupplementation Market, Global, Revenue ($m), 2009–2016 22
Figure 9: DBM Market, Global, Revenue ($m), 2002–2009 24
Figure 10: DBM Market, Global, Revenue ($m), 2009–2016 25
Figure 11: Bone Growth Stimulators Market, Global, Revenue ($m), 2002–2009 27
Figure 12: Bone Growth Stimulators Market, Global, Revenue ($m), 2009–2016 28
Figure 13: Bone Allografts Market, Global, Revenue ($m), 2002–2009 29
Figure 14: Bone Allografts Market, Global, Revenue ($m), 2009–2016 30
Figure 15: Orthobiologics Market, Global, Segment Analysis, 2002 – 2016 32
Figure 16: Orthobiologics Market, US, Revenue ($m), 2002-2009 33
Figure 17: Orthobiologics Market, US, Revenue ($m), 2009-2016 34
Figure 18: Orthobiologics Market, Canada, Revenue ($m), 2002-2009 35
Figure 19: Orthobiologics Market, Canada, Revenue ($m), 2009-2016 36
Figure 20: Orthobiologics Market, Germany, Revenue ($m), 2002-2009 37
Figure 21 Orthobiologics Market, Germany, Revenue ($m), 2009-2016 38
Figure 22: Orthobiologics Market, UK, Revenue ($m), 2002-2009 39
Figure 23: Orthobiologics Market, UK, Revenue ($m), 2009-2016 40
Figure 24: Orthobiologics Market, France, Revenue ($m), 2002-2009 41
Figure 25: Orthobiologics Market, France, Revenue ($m), 2009-2016 42
Figure 26: Orthobiologics Market, Spain, Revenue ($m), 2002-2009 43
Figure 27: Orthobiologics Market, Spain, Revenue ($m), 2009-2016 44
Figure 28: Orthobiologics Market, Italy, Revenue ($m), 2002-2009 45
Figure 29: Orthobiologics Market, Italy, Revenue ($m), 2009-2016 46
Figure 30: Orthobiologics Market, Japan, Revenue ($m), 2002-2009 47
Figure 31: Orthobiologics Market, Japan, Revenue ($m), 2009-2016 48
Figure 32: Orthobiologics Market, China, Revenue ($m), 2002-2009 49
Figure 33: Orthobiologics Market, China, Revenue ($m), 2009-2016 50
Figure 34: Orthobiologics Market, India, Revenue ($m), 2002-2009 51
Figure 35: Orthobiologics Market, India, Revenue ($m), 2009-2016 52
Figure 36: Orthobiologics Market, Australia, Revenue ($m), 2002-2009 53
Figure 37: Orthobiologics Market, Australia, Revenue ($m), 2009-2016 54
Figure 38: Orthobiologics Market, Brazil, Revenue ($m), 2002-2009 55
Figure 39: Orthobiologics Market, Brazil, Revenue ($m), 2009-2016 56
Figure 40: Orthobiologics Market, Global, Company Shares (% Revenue), 2009 57
Figure 41: Medtronic, Inc. , Pipeline Products, 2010 59
Figure 42: Depuy, Pipeline Products, 2010 60
Figure 43: Smith & Nephew , Pipeline Products, 2010 62
Figure 44: Stryker , Pipeline Products, 2010 63
Figure 45: Orthofix International , Pipeline Products, 2010 64
Figure 46: Pipeline Products, Orthobiologics, by Development Stage, Global, 2010 70
Figure 47: Pipeline Products, Orthobiologics, by Segment, Global, 2010 71
Figure 48: Orthobiologics Market Deal Analysis, Value ($m) and Volume, 2006–2010* 85
Companies mentioned
Medtronic Inc.
Genzyme Corporation
Depuy, Inc.(Johnson & Johnson)
Synthes, Inc.
Smith & Nephew Plc
Stryker
Orthofix International N.V
To order this report:
Orthopedic Industry: Orthobiologics - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Check our Company Profile, SWOT and Revenue Analysis!
CONTACT: |
|
Nicolas Bombourg |
|
Reportlinker |
|
Email: [email protected] |
|
US: (805)652-2626 |
|
Intl: +1 805-652-2626 |
|
SOURCE Reportlinker
Share this article